New Antimycotics in the Pipeline – For Ophthalmology Too?

Autor:	Wolfgang Behrens-Baumann
Rok vydání:	2021
Předmět:	0301 basic medicine medicine.medical_specialty business.industry 030106 microbiology Pharmacist medicine.disease Pipeline (software) 03 medical and health sciences Ophthalmology 0302 clinical medicine Ocular mycosis 030221 ophthalmology & optometry medicine Intensive care medicine business Mycosis
Zdroj:	Klinische Monatsblätter für Augenheilkunde. 238:1108-1112
ISSN:	1439-3999 0023-2165
DOI:	10.1055/a-1478-4248
Popis:	Seven new antimycotics are presented that are at different points of development or approval. These substances are mainly first-in-class drugs. They are primarily developed for systemic administration. However, with the support of a pharmacist, the intravenous formulation may be used as eyedrops. In this short review, the activities of the substances against various fungal infections are described. After unsuccessful conventional therapy of fungal eye infections, one of these new substances might be suitable to cure the mycosis.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a4c528be1003ecc173e6238c2da827bf https://doi.org/10.1055/a-1478-4248 Zobrazit plný text záznamu